Reactivos e instrumentos para inmunología, biología celular y biología molecular.
 
> DPPA2 (Developmental Pluripotency-associated Protein 2, Pluripotent Embryonic Stem Cell-related Gene 1 Protein, PESCRG1)

DPPA2 (Developmental Pluripotency-associated Protein 2, Pluripotent Embryonic Stem Cell-related Gene 1 Protein, PESCRG1)

Imprimir Imprimir
Por favor conéctese

Referencia 030920-100ul

embalaje : 100ul

Marca : US Biological

Solicitar más información

Contact local distributor :


Teléfono : +1 850 650 7790

030920 DPPA2 (Developmental Pluripotency-associated Protein 2, Pluripotent Embryonic Stem Cell-related Gene 1 Protein, PESCRG1)

Clone Type
Polyclonal
Host
mouse
Source
human
Swiss Prot
Q7Z7J5
Isotype
IgG1,k
Grade
Ascites
Applications
E WB
Crossreactivity
Hu
Accession #
NP_620170.3
Gene #
DPPA2
Shipping Temp
Blue Ice
Storage Temp
-20°C

DPPA2 may play a role in maintaining cell pluripotentiality.||Applications:|Suitable for use in Western Blot, ELISA.||Recommended Dilution:|ELISA: 1:1000|Western Blot: 1:1000~16000||Storage and Stability:|May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Applications
Product Type: Mab|Isotype: IgG1,k|Clone No: 210CT5.14.6.1|Host: mouse|Source: human|Concentration: Not Determined |Form: Supplied as a liquid, 0.09% sodium azide.|Purity: Ascites|Immunogen: DPPA2 Mab is generated from mouse immunized with DPPA2 recombinant protein.|Specificity: Human||Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Immunogen
DPPA2 Mab is generated from mouse immunized with DPPA2 recombinant protein.
Form
Supplied as a liquid, 0.09% sodium azide.
Purity
Ascites
Specificity
Human
References
Rose, J. Phd, et al. Mol. Med. (2010) In press|Tchabo, N.E., et al. Cancer Immun. 9, 6 (2009)|John, T., et al. Clin. Cancer Res. 14(11):3291-3298(2008)|Monk, M., et al. Mol. Hum. Reprod. 14(6):347-355(2008)|Du, J., et al. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 21(6):542-547(2004)